ArticleCell cycle (Georgetown, Tex.)2014

Identification of ribonucleotide reductase M2 as a potential target for pro-senescence therapy in epithelial ovarian cancer.

Katherine M Aird et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.